Press Releases

Search Press Releases:

Search Input

• All News
• 2021
• 2020
• 2019
• 2018
• 2017
• 2016
• 2015
• 2014
• 2013
• 2012
• 2011
• 2010

Tonix Pharmaceuticals Added to Russell 2000® and Russell 3000® Indexes

June 28, 2021 • 7:00 AM EDT

Commercial Scale Vaccine Manufacturing Facility Advances In The Bitterfoot

June 24, 2021 • 1:30 PM EDT

Tonix Pharmaceuticals Announces Program to Develop TNX-102 SL for the Treatment of Long COVID Syndrome, also Known as Post-Acute Sequelae of COVID-19 (PASC)

June 21, 2021 • 7:00 AM EDT

Tonix Pharmaceuticals to Present at Raymond James Human Health Innovation Conference

June 16, 2021 • 7:00 AM EDT

Tonix Pharmaceuticals to Participate in BIO Digital Conference

June 10, 2021 • 7:00 AM EDT

Tonix Pharmaceuticals Presents Positive Results from Phase 3 RELIEF Study of TNX-102 SL for the Management of Fibromyalgia at the 2021 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

June 3, 2021 • 7:00 AM EDT

Tonix Pharmaceuticals Announces Presentation of Two Posters at the 2021 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting

May 26, 2021 • 7:00 AM EDT

Tonix Pharmaceuticals to Present at May Investor Summit Virtual Conference

May 12, 2021 • 7:00 AM EDT

Tonix Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Highlights

May 10, 2021 • 4:30 PM EDT

Tonix Pharmaceuticals to Participate in Fourth Annual Neuroscience Innovation Forum

April 21, 2021 • 7:00 AM EDT

• « Previous
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• ...41
• Next »